Surface Use Royalties was LandBridge’s largest product and service line in fiscal 2025, bringing in $72.77M of $199.09M (37%).
| Product and Service | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| Surface Use Royalties | $13.22M | $31.62M | $72.77M |
| Easements & Other Surface Related Revenues | $12.64M | $34.12M | $62.00M |
| Resource Sales | $19.83M | $15.35M | $24.72M |
| Oil & Gas Royalties | $20.74M | $16.03M | $12.59M |
| Resource Royalties | $6.43M | $12.84M | $23.03M |
| Other | — | — | $3.98M |
| Total | $72.87M | $109.95M | $199.09M |
LandBridge brought in $199.09M from its six product and service lines in fiscal 2025, the year ended December 31, 2025. LandBridge regrouped these lines after fiscal 2024, so the total does not compare directly with that year's $109.95M. Surface Use Royalties was the largest at $72.77M (36.6%), ahead of Easements & Other Surface Related Revenues at $62.00M (31.1%) and Resource Sales at $24.72M (12.4%). The other three lines brought in $39.60M combined.
Compared with fiscal 2024, Surface Use Royalties grew fastest, up 130.1% to $72.77M, while Oil & Gas Royalties fell the most, down 21.5% to $12.59M.
LandBridge began breaking out Other in fiscal 2025, when it brought in $3.98M.
LandBridge (LB) reports its revenue by product and service. In fiscal 2025, Surface Use Royalties was its largest product and service line, bringing in $72.77M (36.6% of the total), followed by Easements & Other Surface Related Revenues at $62.00M (31.1%).
Surface Use Royalties was LandBridge's largest product and service line in fiscal 2025, bringing in $72.77M, or 36.6% of the $199.09M total across its six product and service lines.
Every figure comes from LandBridge's annual financial filings, as reported. Each line keeps the name LandBridge gives it, and years follow its fiscal calendar.
LandBridge's revenue by product and service goes back to fiscal 2023, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.